HIV or AIDS Diagnostics Market - Global Forecast 2026-2032

The HIV and AIDS diagnostics market is being reshaped by technological innovation, changes in care delivery, and shifting global health priorities. Senior decision-makers face both opportunities and complexities as advancements in testing, data integration, and supply models redefine industry standards.

Market Snapshot: HIV and AIDS Diagnostics Market Growth Trajectory

The HIV and AIDS diagnostics market is entering a phase of robust expansion. From USD 2.60 billion in 2025, it is projected to grow to USD 2.76 billion in 2026. Sustained by a CAGR of 6.56%, the market is forecast to reach USD 4.06 billion by 2032. Key drivers include intensified demand for advanced testing solutions, the broadening scope of diagnostic services into decentralized and remote settings, and the alignment of diagnostics strategies with international public health initiatives.

Scope & Segmentation of the HIV and AIDS Diagnostics Market

This research delivers a comprehensive analysis of the HIV and AIDS diagnostics market structure, enabling decision-makers to assess new pathways to growth while monitoring evolving threats.

Test Types: Antibody assays such as ELISA/EIA, rapid HIV tests, and Western blot confirmatory methods provide core capabilities for initial screening and confirmation. CD4 count tests help evaluate immune function, while viral load testing supports ongoing disease and therapy monitoring.
Product Categories: Consumables, reagents, and diagnostic instruments form the market backbone. There is significant growth in software solutions that support integration of patient data and resource management across healthcare sites.
Testing Methods: Laboratory-based diagnostics remain essential for accuracy. Expansion of point-of-care and self-testing strategies addresses the need for immediate results and improved patient access in distributed care models.
User Settings: Utilization spans blood banks, diagnostic centers, home-based care, hospitals and clinics, as well as research institutions, supporting both clinical practice and public health programs.
Application Domains: Diagnostics are used in disease progression tracking, management of treatment efficacy, and screening initiatives designed for large-scale disease surveillance.
Geographic Coverage: Regional analysis includes the Americas, Europe, Middle East & Africa, and Asia Pacific, providing insights into varied regulatory requirements and market needs affecting technology adoption and investment.
Technology Focus: Next-generation immunoassays, nucleic acid amplification technologies, microfluidics, digital interface solutions, and artificial intelligence are being leveraged to enhance efficiency and predictive accuracy.

Key Takeaways for Senior Decision-Makers

Modern diagnostic systems are supporting earlier detection and enabling richer patient engagement through seamless integration with digital health records and platforms.
The rise of decentralized, point-of-care, and self-administered testing is increasing access but requires enhanced workforce training and rethinking supply chain logistics to maintain responsiveness in diverse settings.
The prominence of genetic resistance monitoring and companion diagnostics is supporting more personalized therapy regimes and prompting updates to clinical practice standards.
Growth in emerging markets is being accelerated by public-private sector cooperation, local manufacturing efforts, and targeted investments to strengthen diagnostic infrastructures.
Supply chain resilience is now a core strategic objective, addressed through collaborative procurement, nearshoring initiatives, and adoption of real-time inventory management tools to support agile operations.
Industry leaders are extending their offerings with modular diagnostic platforms and analytics-driven solutions to help healthcare providers optimize workflows and generate actionable insights from patient data.

Tariff Impact and Supply Chain Implications

The introduction of a new United States tariff schedule in early 2025 has altered the cost structures and timeframes within the HIV diagnostics value chain. Manufacturers and distributors are adjusting by pursuing localized sourcing, investing in regional manufacturing, and expanding their network of suppliers. Operational strategies now emphasize building safety stock and renegotiating agreements to bolster flexibility and manage risks associated with changing trade conditions.

Methodology & Data Sources

The analysis is grounded in structured primary interviews, collaboration with industry partners, robust regulatory data, and insights derived from clinical trial outcomes. Quantitative analysis, scenario planning, and geospatial assessment ensure the research delivers actionable and relevant intelligence.

Why This Report Matters for C-Level Executives and Strategists

Facilitates informed investment and product strategy decisions by pinpointing high-growth market segments and emerging technology trends.
Clarifies operational risks associated with regulatory shifts, supply chain complexities, and regional disparities, enabling effective market participation.
Provides the foundation for benchmarking competitive status and exploring collaborative ventures to adapt to developments in diagnostic service delivery.

Conclusion

Adoption of advanced diagnostics, expansion of care models, and targeted supply chain strategies are influencing the future of the HIV and AIDS diagnostics sector. This research equips leaders to anticipate change, refine business priorities, and maintain relevance in a dynamic global market.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. HIV or AIDS Diagnostics Market, by Test Type

8.1. Antibody Tests
8.1.1. ELISA/EIA
8.1.2. Rapid Tests
8.1.3. Western Blot Test
8.2. CD4 Tests
8.3. Viral Load Tests

9. HIV or AIDS Diagnostics Market, by Type of Product

9.1. Consumables & Reagents
9.2. Instruments & Kits
9.3. Software
9.4. Testing Services

10. HIV or AIDS Diagnostics Market, by Testing Method

10.1. Laboratory-Based Testing
10.2. Point-Of-Care Testing
10.3. Self-Testing

11. HIV or AIDS Diagnostics Market, by End-User

11.1. Blood Banks & Transfusion Centers
11.2. Diagnostic Centers
11.3. Home Care Settings
11.4. Hospitals & Clinics
11.5. Research Institutes

12. HIV or AIDS Diagnostics Market, by Application

12.1. Disease Progression
12.2. Monitoring
12.3. Screening

13. HIV or AIDS Diagnostics Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. HIV or AIDS Diagnostics Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. HIV or AIDS Diagnostics Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States HIV or AIDS Diagnostics Market
17. China HIV or AIDS Diagnostics Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. ACON Laboratories
18.7. Beckman Coulter, Inc.
18.8. Becton, Dickinson and Company
18.9. Bio-Rad Laboratories
18.10. bioMérieux SA
18.11. Chembio Diagnostics, Inc.
18.12. Danaher Corporation
18.13. DiaSorin S.p.A.
18.14. ELITechGroup
18.15. Euroimmun Medizinische Labordiagnostika AG
18.16. F. Hoffmann-La Roche Ltd.
18.17. Hologic, Inc.
18.18. InBios International, Inc.
18.19. OraSure Technologies
18.20. Ortho Clinical Diagnostics, Inc.
18.21. SD Biosensor Inc.
18.22. Siemens Healthineers AG
18.23. Thermo Fisher Scientific, Inc.
18.24. Trinity Biotech plc
18.25. Viracor Eurofins Diagnostic Services
18.26. Wondfo Biotech Co. Ltd.

List of Figures

FIGURE 1. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA/EIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA/EIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA/EIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY WESTERN BLOT TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY WESTERN BLOT TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY WESTERN BLOT TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY CD4 TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY CD4 TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY CD4 TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY VIRAL LOAD TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY VIRAL LOAD TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY VIRAL LOAD TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY LABORATORY-BASED TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY LABORATORY-BASED TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY LABORATORY-BASED TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SELF-TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SELF-TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SELF-TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY BLOOD BANKS & TRANSFUSION CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY BLOOD BANKS & TRANSFUSION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY BLOOD BANKS & TRANSFUSION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY DISEASE PROGRESSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY DISEASE PROGRESSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY DISEASE PROGRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. EUROPE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. EUROPE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 103. EUROPE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 104. EUROPE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 105. EUROPE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 106. EUROPE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 116. AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 117. AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 118. AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 119. AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 120. AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. ASEAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. ASEAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 131. ASEAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 132. ASEAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 133. ASEAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 134. ASEAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 135. ASEAN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. GCC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GCC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 138. GCC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 139. GCC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 140. GCC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 141. GCC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 142. GCC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. BRICS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. BRICS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 152. BRICS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 153. BRICS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 154. BRICS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 155. BRICS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 156. BRICS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. G7 HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. G7 HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 159. G7 HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 160. G7 HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 161. G7 HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 162. G7 HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 163. G7 HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. NATO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. NATO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 166. NATO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 167. NATO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 168. NATO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 169. NATO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 170. NATO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 180. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 181. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2032 (USD MILLION)
TABLE 182. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2032 (USD MILLION)
TABLE 183. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
TABLE 184. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 185. CHINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this HIV or AIDS Diagnostics market report include:

Abbott Laboratories
ACON Laboratories
Beckman Coulter, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories
bioMérieux SA
Chembio Diagnostics, Inc.
Danaher Corporation
DiaSorin S.p.A.
ELITechGroup
Euroimmun Medizinische Labordiagnostika AG
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
InBios International, Inc.
OraSure Technologies
Ortho Clinical Diagnostics, Inc.
SD Biosensor Inc.
Siemens Healthineers AG
Thermo Fisher Scientific, Inc.
Trinity Biotech plc
Viracor Eurofins Diagnostic Services
Wondfo Biotech Co. Ltd.

Table Information

Report Attribute	Details
No. of Pages	181
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.76 Billion
Forecasted Market Value ( USD ) by 2032	$ 4.06 Billion
Compound Annual Growth Rate	6.5%
Regions Covered	Global
No. of Companies Mentioned	23

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3447EUR$3,939USD£2,988GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3719EUR$4,249USD£3,223GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5040EUR$5,759USD£4,368GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6099EUR$6,969USD£5,286GBP

Market Snapshot: HIV and AIDS Diagnostics Market Growth Trajectory

Scope & Segmentation of the HIV and AIDS Diagnostics Market

Key Takeaways for Senior Decision-Makers

Tariff Impact and Supply Chain Implications

Methodology & Data Sources

Why This Report Matters for C-Level Executives and Strategists

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030

HIV Diagnostics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

HIV Supplemental Assays & Control Kit Market - Global Forecast 2025-2030

Infectious Disease Diagnostic Market - Global Forecast 2026-2032

HIV Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034